Introduction: Dyslipidemia, is one of the major causes of cardiovascular disease in dialysis patients.
Objectives: This investigation sought to assess the association of serum magnesium level and blood lipids profile in patients under peritoneal dialysis and hemodialysis.
Patients and Methods: This cross-sectional investigation was conducted on 110 dialysis patients. Serum lipids and magnesium levels were assessed. Data were analyzed using t-test and Pearson’s correlation.
Results: The mean patients’ age was 46.1±14.7 years. In peritoneal dialysis patients, who were not under treatment of antilipid drugs, the correlation of serum magnesium with triglyceride and VLDL was significant (p<0.05), while the association of serum magnesium with total cholesterol and LDL-C was significant, only in subgroup who were under treatment of antilipid drugs (p<0.05). In hemodialysis patients, the correlation of serum magnesium with total cholesterol, triglyceride and VLDL was significant (p<0.05).
Conclusions: This study revealed that serum magnesium had correlation with serum lipids and could influence to atherosclerosis and cardiovascular disease in dialysis patients.